Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRHR1 levels in AA patients lead to increased inflammation.

Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

PRP injections can improve stress incontinence symptoms in women.

PRP injections may effectively treat stress urinary incontinence in women.

PRP injections can effectively improve stress urinary incontinence in women.

PRP injections effectively improve stress urinary incontinence in women.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

People with Lichen Planus have thicker carotid artery walls, but it's not solely due to Lichen Planus when other factors are considered.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Certain genetic variations in the A2M gene are linked to better milk quality in Murrah buffaloes.

Injectable skin boosters effectively rejuvenate aging skin by improving hydration and elasticity.

Low-Level Laser Therapy can stimulate healing and cell function, potentially leading to wider medical use.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

PRP helps heal and repair tissues in medicine but needs more research for better use.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

EGFR inhibitors for lung cancer can cause severe skin issues.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

GLP-1 agonists may help treat certain skin conditions.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.